Conferences - Results from #9000

Viewing 9001-9020 of 11775 articles

TAT-10: Quality Assurance and Labeling Chemistry Qualification for cGMP Production of Astatine-211-labeled anti-CD45 Antibodies

TAT-10: Development of Effective Chelators for Th227 to be Used in Targeted Thorium Conjugates

TAT-10: Spectroscopic and Computational Studies of Actinium Coordination Chemistry

TAT-10: A Novel Micro-Actinium225-Bismuth212 Biomedical Generator System

TAT-10: US DOE Tri-Lab Research Effort to Provide Accelerator produced Ac225 for radiotherapy: 2017 Update

TAT-10: Production of a Thorium/Actinium Generator at the Canadian Nuclear Laboratories

TAT-10: Progress Toward an Alternate Method for Production of Ac-225

TAT-10: Radium 223 from Bench to Bedside, and Future Directions for Targeted Alpha Therapy

Bladder Cancer Academy 2017: Bladder Cancer Biomarkers: New and Old

Bladder Cancer Academy 2017: Bladder-Sparing Strategies

Bladder Cancer Academy 2017: Neoadjuvant and Adjuvant Chemotherapy Bladder Cancer

Bladder Cancer Academy 2017: Genitourinary Oncology: A Peek Over the Horizon

Bladder Cancer Academy 2017: Immunotherapy of Advanced Bladder Cancer: The Next Frontier

Bladder Cancer Academy 2017: Immunotherapy of Renal Cell Carcinoma

Bladder Cancer Academy 2017: Intravesical Therapy: When Bacillus Calmette-Guerin Fails

Bladder Cancer Academy 2017: AUA Guidelines: Muscle-Invasive Bladder Cancer

Bladder Cancer Academy 2017: Why LUGPA Embraces Managing Advanced Genitourinary Cancers

Bladder Cancer Academy 2017: AUA Guidelines: Non-Muscle Invasive Bladder Cancer

Bladder Cancer Academy 2017: Quality Indicators and Enhanced Imaging in Cystoscope and TURBT

Bladder Cancer Academy 2017: Targeted Therapies for Renal Cell Carcinoma

446
447
448
449
450
451
452
453
454
455